RIM
PFE icon

RS Investment Management’s Pfizer PFE Stock Holding History

RS Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$27.9M Sell
835,827
-897,966
-52% -$28.7M 0.29% 133
2016
Q1 		$48.8M Buy
1,733,793
+11,341
+0.7% +$324K 0.48% 67
2015
Q4 		$52.8M Sell
1,722,452
-195,707
-10% -$6.16M 0.47% 74
2015
Q3 		$57.2M Sell
1,918,159
-143,449
-7% -$4.6M 0.51% 67
2015
Q2 		$65.6M Sell
2,061,608
-679,303
-25% -$22.1M 0.56% 59
2015
Q1 		$90.5M Sell
2,740,911
-125,184
-4% -$3.98M 0.81% 29
2014
Q4 		$84.7M Buy
2,866,095
+296,912
+12% +$8.51M 0.76% 28
2014
Q3 		$72.1M Buy
2,569,183
+97,889
+4% +$2.75M 0.66% 42
2014
Q2 		$69.6M Buy
2,471,294
+278,811
+13% +$7.95M 0.58% 52
2014
Q1 		$66.8M Buy
2,192,483
+8,326
+0.4% +$248K 0.39% 68
2013
Q4 		$63.5M Sell
2,184,157
-35,309
-2% -$1.03M 0.39% 68
2013
Q3 		$60.5M Sell
2,219,466
-21,501
-1% -$585K 0.39% 71
2013
Q2 		$59.6M Buy
+2,240,967
New +$61.9M 0.43% 60

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

RS Investment Management's PFE Position: Q2 2016 in Review

RS Investment Management reduced its Pfizer (PFE) stake by 52% in Q2 2016, selling an estimated $28.7M and leaving 835,827 shares worth $27.9M. The position accounts for 0.29% of the portfolio, ranked #133.

RS Investment Management first reported a position in PFE in Q2 2013 and has held it in 13 quarters since. The position peaked at $90.5M in Q1 2015. 1,992 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

  • RS Investment Management held 835,827 shares of Pfizer worth $27.9M as of Q2 2016.
  • RS Investment Management sold 897,966 Pfizer shares in Q2 2016, an estimated $28.7M.
  • Pfizer made up 0.29% of RS Investment Management's portfolio in Q2 2016, its #133 holding.
  • RS Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 13 quarters since.
  • RS Investment Management's Pfizer position peaked at $90.5M in Q1 2015.
  • 1,992 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.